Boston Scientific (BSX) news
Recent news
Boston Scientific Corp: Truist Securities cuts target price to $51 from $57
AInvest Wire · 19h agoDundas Minerals - Trading halt requested pending capital raising announcement
Dundas Minerals Ltd (ASX: DUN) has requested a trading halt on the Australian Securities Exchange (ASX), pending a capital raising initiative . The halt, which was announced on February 9, 2026, is part of the company’s ongoing efforts to secure additional funding . The company has previously…
AInvest Wire · 3d agoBoston Scientific Corp: Leerink partners cuts target price to $55 from $60
Leerink Partners has revised its price target for Boston Scientific Corp (BSX) to $55 from $60, reflecting a reassessment of the company's near-term outlook. The adjustment comes amid ongoing market volatility and evolving dynamics in the medical device sector. While the firm maintains a…
AInvest Wire · 5d agoBoston Scientific: Will establish three reportable segments - Interventional Therapies, Rhythm Solutions and MedSurg also effective Jan.1
AInvest Wire · 7d agoBoston Scientific Corp - To establish three reportable segments effective Jan. 1, 2027
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.